With a recovery rate of 98.91 percent, the current active COVID-19 caseload in India amounts to 1,524, revealed sources.
COVID-19 in India
The start of the year 2020 has an outbreak of a //new coronavirus (2019-nCoV). In early December 2019, a number of pneumonia cases were reported in individuals exposed to a seafood and animal wholesale market in the city of Wuhan, Hubei province, China. Soon this new virus strain that was not reported in humans previously, was discovered to be the cause of the outbreak and worse was that the pneumonia could turn fatal. Within a month of the outbreak on 30 January the World Health Organization (WHO) declared the 2019-nCoV outbreak a global emergency.
Fluvoxamine: An OCD Drug can Prevent Covid-19 Patients from Hospitalization
Fluvoxamine has been proven among one such drug that could be used to treat COVID-19. Dozens of COVID patients showed no clinical deterioration in their symptoms when treated with a drug, fluvoxamine.
Fluvoxamine has been proven among one such drug that could be used to treat COVID-19. Dozens of COVID patients showed no clinical deterioration in their symptoms when treated with a drug, fluvoxamine.
‘COVID-19 in India: From January 3, 2020, until 6:30 pm CEST on August 16, 2023, India has documented 44,996,599 confirmed cases of COVID-19 and 531,925 associated deaths, as reported to WHO. #covid-19 #coronavirus #covidinindia ’
According to the Ministry's data, the death toll rose to 5,31,929 as one more succumbed to the disease. Also in the same period, 47 people recupercated from the disease, pushing total number of recoveries to 4,44,63,580. According to the Ministry data, over 220.67 crore doses of COVID-19 vaccine have been administered so far (1✔ ✔Trusted Source
NATIONAL COVID-19 VACCINATION PROGRAMME MEETS ITS GOALS BY OVERCOMING R&D AND LOGISTICAL CHALLENGES, SAYS ECONOMIC SURVEY 2022-23
Go to source).
Reference:
- NATIONAL COVID-19 VACCINATION PROGRAMME MEETS ITS GOALS BY OVERCOMING R&D AND LOGISTICAL CHALLENGES, SAYS ECONOMIC SURVEY 2022-23 - (https://pib.gov.in/PressReleasePage.aspx?PRID=1894907)
Test your Knowledge on Coronavirus (COVID-19)
Coronavirus is a large positive-strand RNA virus that is surrounded by a protein envelope. The virus obtains its name from the S protein spikes on its surface, which resemble a crown. The overall pattern of increasing coronavirus cases is shown to ...
Coronavirus is a large positive-strand RNA virus that is surrounded by a protein envelope. The virus obtains its name from the S protein spikes on its surface, which resemble a crown. The overall pattern of increasing coronavirus cases is shown to ...
Do Coronaviruses Pose a Risk for Spill Over?
A novel network-based approach helps identify which virus to prioritize for more human surveillance to avoid the risk of spillover.
A novel network-based approach helps identify which virus to prioritize for more human surveillance to avoid the risk of spillover.
